Distal Radius Fracture - Treatment Comparison

NCT ID: NCT01883063

Last Updated: 2015-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective multi-site study. Subjects with distal radius fractures will be enrolled. Subjects will be treated surgically with a Sonoma WRx™ device or managed non-operatively with a splint or cast. Subjects will be enrolled in each group according to physician's standard of care (either casting/splinting or surgery) for distal radius fractures. Subjects will be enrolled based on the study's inclusion/exclusion criteria with a final qualifying decision made by a group of three independent adjudicators. The final qualifying review should allow for similar patient groups within each arm of the study due to the variability that can arise in fracture classification. Review by the adjudicators should be completed within 1 week.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Minimally Displaced Intra-articular Distal Radius Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

WRx™ Intramedullary Nail

Patients in this arm of the study will be treated with a minimally invasive WRx™ Intramedullary Nail for their wrist fracture.

Group Type EXPERIMENTAL

Surgical Treatment

Intervention Type DEVICE

Patients will be treated for distal radius fractures surgically with a WRx™ Intramedullary Nail

Non surgical treatment (Cast)

Patients in this arm of the study will be treated with a cast for their wrist fracture.

Group Type ACTIVE_COMPARATOR

Non surgical Treatment (Cast or splint)

Intervention Type DEVICE

Patients will be treated for distal radius fractures non surgically with a cast or splint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgical Treatment

Patients will be treated for distal radius fractures surgically with a WRx™ Intramedullary Nail

Intervention Type DEVICE

Non surgical Treatment (Cast or splint)

Patients will be treated for distal radius fractures non surgically with a cast or splint

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Closed extra-articular distal radius fracture or a minimally displaced intra-articular fracture
* Fracture classified as an AO/OTA A2, A3, C1 or C2 with or without an ulnar styloid fracture
* Must be treated within the first 14 days of injury,
* Male or female greater than or equal to 65 years of age.
* Able to understand the requirements of the study, provide a written informed consent and comply with the study protocol
* Ability to understand and provide written authorization for use and disclosure of personal health information
* Fracture that can be treated closed with or without closed reduction

Exclusion Criteria

* Concomitant contralateral or ipsilateral upper extremity fractures
* Ipsilateral ulna (excluding styloid) fracture
* Open fracture
* Previous ipsilateral distal radius fracture in the 2 years prior to enrollment with deformity
* Unstable distal radioulnar joint after fracture fixation
* Fractures where the transverse fracture line is less than 10mm from the distal radius joint surface
* Artery or Nerve injury secondary to fracture
* History of alcoholism
* Currently on chemotherapy or radiation therapy
* Currently on worker's compensation
* Rheumatoid arthritis or other inflammatory arthropathies.
* History of chronic pain issues or psychiatric disorder that precludes reliable follow-up.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sonoma Orthopedic Products, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cadence Health

Winfield, Illinois, United States

Site Status

University of Missouri

Columbia, Missouri, United States

Site Status

John Peter Smith Hospital

Fort Worth, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WRx-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

LPHP-Philos-PHN Conservative Treatment
NCT00205959 COMPLETED PHASE4